TrialBritish journal of haematology2020

Multi-dimensional analysis identifies an immune signature predicting response to decitabine treatment in elderly patients with AML.

Chenchen Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.